- Filed
- May 8, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 2, 2025 | 665.92M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $642.38M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $643.71M |
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $6.75M |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $6.75M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $580.89M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $585.97M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $65.56M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $64.65M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $892.6M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $893.32M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $703.86M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $689.71M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $1.77B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $1.77B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 663.57M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $451K |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $43.71M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $855.71M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $844.97M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.01 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.01 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $40.44M |
| Net Income | Q1 2025 · Mar 31, 2024 | $7.75M |
| Operating Income | Q1 2025 · Mar 31, 2024 | $19.62M |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $71.34M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $27.56M |
| Revenue | Q1 2025 · Mar 31, 2024 | $98.91M |